Application of pharmaceutical composition in preparation of drugs for treating cancers
A technology of composition and medicine, which is applied in the application field of pharmaceutical composition in the preparation of drugs for treating cancer, to achieve the effects of inhibiting tumor cell growth, reducing the formation of clones, and having low toxic and side effects
Active Publication Date: 2020-08-18
杜晶晶
View PDF1 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
And there is currently no report on the combination of 5-fluorouracil and Shuganning preparations for the treatment of tumors
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0051] Shuganning preparations were purchased from Ruihe Pharmaceutical Co., Ltd. Shuganning injection (20190420), 5-fluorouracil (Sigma, F6627).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention discloses a new application of a pharmaceutical composition, and concretely relates to an application of the pharmaceutical composition in the preparation of cancer treatment medicines,and the pharmaceutical composition comprises a Shuganning preparation. The pharmaceutical preparation can effectively inhibit the growth of multiple cancer cells, reduce the formation of clone numberof cancer cells, induce cancer cell death, block the cancer cell period in the S phase, effectively inhibit the growth of transplanted tumor of nude mice, does not influence the weight of nude mice, can effectively treat cancer, and has low toxic and side effects. The Shuganning preparation in the traditional Chinese medicine composition can selectively kill cancer cells, does not influence the growth of normal cells, and has a synergistic anti-tumor effect (wherein synergistic index, CI is less than 1) when being combined with 5-fluorouracil for use.
Description
technical field [0001] The invention relates to the application of a pharmaceutical composition in the preparation of medicines for treating cancer. The pharmaceutical composition is composed of Shuganning preparation and 5-fluorouracil. It also relates to the application of the Shuganning preparation in the pharmaceutical composition in the preparation of medicines for treating cancer. Background technique [0002] Cancer is one of the most harmful diseases to human life and health, and a large number of people die of cancer every year. The research and development of anticancer drugs has always been a hot spot in pharmaceutical research. Chemotherapeutic drugs commonly used in clinical practice have severe side effects, seriously affecting the health and quality of life of patients. The cost of targeted chemotherapy drugs is high, and long-term use is unaffordable for patients. Especially for triple-negative breast cancer (ER-negative, PR-negative, HER2 / neu not overexpr...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/744A61P35/00A61K31/7048A61K31/513
CPCA61K36/282A61K36/744A61K31/7048A61K36/195A61K36/315A61K36/074A61K31/513A61P35/00A61K2300/00Y02A50/30
Inventor 马文哲杜晶晶王历爽龙泽黄晓明林婉君张娜郑博文杨友钟芳芳申云富覃祥黄喆陈俊和林倩煜
Owner 杜晶晶
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com